Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate superiority of CHF5188 pMDI 400/4µg administered once-a-day in the morning over budesonide extrafine pMDI on trough FEV1 after 4 weeks of treatment in persistent moderate or severe asthmatic patients partly controlled with ICS or ICS/LABA.
Inclusion criteria
- Moderate or Severe Persistent Asthma